Trevi Therapeutics Inc (OQ:TRVI)

Business Focus: Biopharmaceuticals

May 07, 2019 09:22 am ET
Trevi Therapeutics Announces Pricing of Initial Public Offering
Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced the pricing of its initial public...